Nuvation Bio, a global oncology company dedicated to addressing some of the most challenging areas in cancer care, has announced that the U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) …
Intensity Therapeutics, Inc., a late-stage biotechnology firm, focuses on discovering and developing proprietary cancer treatments using its non-covalent drug-conjugation technology. This approach is designed to destroy tumors while enhancing the …
